Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Aug 29, 2024

BUY
$87.74 - $117.27 $535,740 - $716,050
6,106 New
6,106 $593,000
Q1 2023

May 02, 2023

SELL
$87.74 - $117.27 $3,772 - $5,042
-43 Reduced 0.7%
6,106 $593,000
Q3 2022

Nov 14, 2022

BUY
$82.16 - $96.94 $3,779 - $4,459
46 Added 0.75%
6,149 $521,000
Q2 2022

Aug 03, 2022

BUY
$71.48 - $86.85 $7,148 - $8,685
100 Added 1.67%
6,103 $505,000
Q1 2022

May 04, 2022

BUY
$74.28 - $92.69 $1,857 - $2,317
25 Added 0.42%
6,003 $462,000
Q4 2021

Feb 02, 2022

BUY
$71.72 - $91.47 $428,742 - $546,807
5,978 New
5,978 $528,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Waldron Private Wealth LLC Portfolio

Follow Waldron Private Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Waldron Private Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waldron Private Wealth LLC with notifications on news.